Skip to content

Research

New CRISPR/Cas9 gene editing tool indicates a 35% visual acuity improvement in model of autosomal dominant retinitis pigmentosa

Research conducted at the Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, has shown that CRISPR/Cas9 gene editing technology may be capable of correcting dominant… Read More »New CRISPR/Cas9 gene editing tool indicates a 35% visual acuity improvement in model of autosomal dominant retinitis pigmentosa

Research suggests that the impact of individualized patient assessment and diabetes-risk education on glycemic control may not be sufficiently effective

Research, conducted across 42 ophthalmology centres in the United States, has reported that point-of-care measurement of hemoglobin A1c (HbA1c), combined with personalized diabetes risk assessment… Read More »Research suggests that the impact of individualized patient assessment and diabetes-risk education on glycemic control may not be sufficiently effective

Death of retinal ganglion cells (RGCs) may be mediated by up-regulation of a kinase inhibitor in concert with genetic risk variants

Collaborative research between research groups in the US and China has indicated a mechanistic link between high-risk genetic alleles found to be associated with primary… Read More »Death of retinal ganglion cells (RGCs) may be mediated by up-regulation of a kinase inhibitor in concert with genetic risk variants